ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PTGX Protagonist Therapeutics Inc

26.58
-0.46 (-1.70%)
Apr 15 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 441,002
Bid Price 26.21
Ask Price 27.98
News -
Day High 27.35

Low
13.72

52 Week Range

High
33.34

Day Low 26.32
Company Name Stock Ticker Symbol Market Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.46 -1.70% 26.58 20:00:00
Open Price Low Price High Price Close Price Prev Close
27.18 26.32 27.35 26.58 27.04
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,076 441,002 $ 26.71 $ 11,778,920 - 13.72 - 33.34
Last Trade Time Type Quantity Stock Price Currency
19:11:56 1 $ 27.20 USD

Protagonist Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.55B 58.27M - 60M -78.96M -1.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Protagonist Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PTGX Message Board. Create One! See More Posts on PTGX Message Board See More Message Board Posts

Historical PTGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.0629.2126.3228.05615,872-1.48-5.27%
1 Month28.8129.7326.3228.21568,570-2.23-7.74%
3 Months25.0333.3424.2128.01705,8861.556.19%
6 Months15.3933.3413.7223.38723,00111.1972.71%
1 Year19.0233.3413.7223.00827,6567.5639.75%
3 Years26.1550.546.9121.02974,6780.431.64%
5 Years11.1250.544.4719.74754,47915.46139.03%

Protagonist Therapeutics Description

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment.

Your Recent History

Delayed Upgrade Clock